SYNOPSYS INC
Financial highlights
| Metric | FY 10/31/25 | FY 10/31/24 | FY 10/31/23 | FY 10/31/22 | FY 10/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $7.1B | $6.1B | $5.3B | $5.1B | $4.2B |
| Cost of revenue | $1.6B | $1.2B | $1.0B | $898.0M | $861.8M |
| Gross profit | $5.4B | $4.9B | $4.3B | $3.7B | $3.3B |
| Research and development | $2.5B | $2.1B | $1.8B | $1.6B | $1.5B |
| Operating expenses | $4.5B | $3.5B | $3.0B | $2.6B | $2.6B |
| Operating income | $914.9M | $1.4B | $1.3B | $1.1B | $734.8M |
| Interest expense | $446.7M | $36.8M | $1.2M | $1.7M | $3.4M |
| Pretax income | $1.4B | $1.5B | $1.3B | $1.1B | $805.5M |
| Income tax expense | $56.0M | $99.7M | $90.2M | $139.4M | $49.2M |
| Net income | $1.3B | $2.3B | $1.2B | $984.6M | $757.5M |
| Balance Sheet | |||||
| Cash and equivalents | $2.9B | $3.9B | $1.4B | $1.4B | $1.4B |
| Current assets | $6.0B | $6.5B | $3.4B | $3.0B | $2.8B |
| Total assets | $48.2B | $13.1B | $10.3B | $9.4B | $8.8B |
| Current liabilities | $3.7B | $2.7B | $3.0B | $2.8B | $2.4B |
| Total liabilities | $19.9B | $4.1B | $4.1B | $3.9B | $3.5B |
| Total debt | $13.6B | — | — | — | — |
| Stockholders' equity | $28.3B | $9.0B | $6.1B | $5.5B | $5.3B |
| Cash Flow Statement | |||||
| Cash from operations | $1.5B | $1.4B | $1.7B | $1.7B | $1.5B |
| Depreciation and amortization | $660.4M | $295.1M | $247.1M | $228.4M | $203.7M |
| Stock-based compensation | $893.3M | $692.3M | $563.3M | $459.0M | $345.3M |
| Capital expenditure | $169.5M | $139.5M | $189.6M | $136.6M | $93.8M |
| Free cash flow | $1.3B | $1.3B | $1.5B | $1.6B | $1.4B |
| Share repurchases | $0 | $0 | $1.2B | $1.1B | $753.1M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 191.5M · Free float 93.1%
Annual filing data through FY ended October 31, 2025; float as of July 11, 2026.